Reaction
Device Safety Feature Issue reporting signals
As of the last recalculation, Device Safety Feature Issue appears in 943 FAERS reports alongside 5 co-occurring drug terms. The strongest observed disproportionality signal is ABATACEPT (PRR 364.5).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Abatacept | 669 | 364.5 | 366.3 |
| Enoxaparin Sodium | 118 | 51.6 | 51.7 |
| Goserelin | 17 | 28.4 | 28.5 |
| Lanreotide Acetate | 4 | 11.3 | 11.3 |
| Romosozumab-Aqqg | 4 | 6.5 | 6.5 |